Back to results
US 8,044,104 B2Granted
Prostaglandin derivative-containing aqueous liquid preparation
AssigneeTaisho Pharmaceutical Co., Ltd.
InventorsKaori Nishizaki, Takayuki Sato, Kentaro Goto, Kuniaki Ishii
Life of this patent
Estimating the term…
Abstract
Provided is an aqueous liquid preparation comprising: (a) any one of a prostaglandin derivative being represented by the following formula (I), a pharmaceutically acceptable salt thereof and a hydrate thereof; and (b) at least one polyol of glycerin, propylene glycol, dipropylene glycol and 1,3-butylene glycol.
Claims3
An aqueous liquid preparation comprising:
- (a) any one of a prostaglandin derivative represented by the following formula (I) and a pharmaceutically acceptable salt thereof:
- (b) 1,3-butylene glycol, wherein
- the one of the prostaglandin derivative represented by the formula (I), the pharmaceutically acceptable salt thereof, which is the component (a), is 0.0001 to 0.02 (w/v %) of the total of the aqueous liquid preparation, and
- a content of 1,3-butylene glycol, which is the component (b), is 30 to 80(w/v %) of the total of the aqueous liquid preparation.
1 more element
Dependencies are inferred from the claim text.